Elsevier

Biological Psychiatry

Volume 34, Issue 4, 15 August 1993, Pages 240-252
Biological Psychiatry

Improvement in symptoms of depression and in an index of life stressors accompany treatment of severe hypertriglyceridemia

https://doi.org/10.1016/0006-3223(93)90078-RGet rights and content

Abstract

In 14 men and nine women referred because of severe primary hypertriglyceridemia, our specific aim in a 54-week single-blind treatment (Rx) period was to determine whether triglyceride (TG) lowering with a Type V diet and Lopid would lead to improvement in symptoms of depression, improvement in an index of life stressors, change in locus of control index, and improved cognition, as serially tested by Beck (BDI), Hassles (HAS) and HAS intensity indices, Locus of Control index, and the Folstein Mini-Mental status exam. On Rx, median TG fell 47%, total cholesterol (TC) fell 15%, and HDLC rose 19% (all p ≤ 0.001). BDI fell at all nine Rx visits (p ≤ 0.001), a major reduction in a test of depressive symptoms. The HAS score also fell at all nine visits (p ≤ 0.05−≤ 0.001). Comparing pre-Rx baseline BDI vs BDI at 30 and 54 weeks on Rx, there was a major shift towards absence or amelioration of depressive symptoms (χ2 = 5.9, p = 0.016). On Rx, the greater the percent reduction in TG, the greater the percent fall in BDI (r = 0.41, p ≤ 0.05); the greater the percent reduction in TC, the greater the percent fall in HAS (r = 0.41, p ≤ 0.05). Improvement in the BDI and HAS accompanied treatment of severe hypertriglyceridemia, possibly by virtue of improved cerebral perfusion and oxygenation. There may be a reversible causal relationship between high TG and symptoms of depression.

References (56)

  • N. Bradburn

    The Structure of Well Being

    (1969)
  • G. Caimi et al.

    Blood rheology changes during bezafibrate treatment

    Br J Clin Pract

    (1988)
  • L.A. Carlson et al.

    Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with Clofibrate and nicotinic acid

    Acta Med Scand

    (1988)
  • G. Ciuffetti et al.

    Hemorheological activity of gemfibrozil in primary hyperlipidemias

  • A. Clauss

    Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens

    Acta Haematol

    (1957)
  • Consensus Conference Treatment of Hypertriglyceridemia

    JAMA

    (1987)
  • Consensus Development Conference on triglyceride, high density lipoprotein, and coronary heart disease

    Clinical Courier

    (1992)
  • L.R. Derogatis et al.

    Dimensions of outpatient neurotic pathology: Comparison of clinical version an empirical assessment

    J Consult Psychol

    (1970)
  • R.S. Elkeles et al.

    Effect of treatment of hyperlipidaemia on haemostatic variables

    Br Med J

    (1980)
  • E. Eriksson et al.

    Determination of plasminogen activator inhibitor in plasma using t-PA and a chromogenic single-point poly D-lysine stimulated assay

    Thromb Res

    (1988)
  • R.W. Fallat et al.

    Familial and acquired type V hyperlipoproteinemia

    Atherosclerosis

    (1975)
  • C.J. Glueck et al.

    Lipoprotein Metabolism in the Elderly

  • C.J. Glueck et al.

    Safety and efficacy of combined Lopid-Mevacor therapy for primary dyslipoproteinemias

    J Lab Clin Med

    (1990)
  • P. Harcos et al.

    Intermittent cerebral symptoms in type V hyperlipoproteinemia

    Eur Neurol

    (1976)
  • K.M. Heilman et al.

    Hyperlipidemic dementia

    Arch Neurol

    (1974)
  • A.D. Kanner et al.

    Comparison of two modes of stress measurement: daily hassles and uplifts versus major life events

    J Behav Med

    (1981)
  • W. Koenig et al.

    Lovastatin improves blood rheology in primary hypercholesterolemia (abstract)

    Eur Heart J

    (1991)
  • W. Koenig et al.

    Association between rheology and components of lipoproteins in human blood

    Circulation

    (1992)
  • Cited by (41)

    • Do statins have an effect on depressive symptoms? A systematic review and meta-analysis

      2019, Journal of Affective Disorders
      Citation Excerpt :

      Therefore, statins by reducing inflammation and oxidative stress may help reduce the likelihood of cardiovascular events and depression. Lastly, it has also been suggested that statins improve brain perfusion and oxygenation (Glueck et al., 1993) and thus improve depression. Whatever the mechanism might be, the results of the current meta-analysis provide optimism for further investigating the efficacy of statins in larger trials to confirm these findings.

    • Post stroke depression: The sequelae of cerebral stroke

      2018, Neuroscience and Biobehavioral Reviews
      Citation Excerpt :

      While screening for depression, statins can be recommended since the risk of CVD increases with depression (O’Neil, 2012). Statins can have a very important role in improving cerebral perfusion and oxygenation (Glueck et al., 1993). Statins can be thus useful for treating depressive symptoms, however, further studies are mandatory to validate their efficacy.

    • Unfairness and the social gradient of metabolic syndrome in the Whitehall II Study

      2007, Journal of Psychosomatic Research
      Citation Excerpt :

      Recent research proposed psychosocial characteristics such as chronic stress [17], work stress [18], job control [19], and social isolation [20] as plausible explanatory factors for one's social position and/or the metabolic syndrome. When considering separate components of the metabolic syndrome, psychological distress is associated with greater fasting glucose [21], blood pressure [22], lipids [23], insulin levels [24], central obesity [25], and triglycerides [26]. Psychosocial factors also influence behavioral risk factors such as smoking and physical inactivity [27] that have been found to be important determinants of metabolic disorders [28,29].

    • Vascular nutritional correlates of late-life depression

      2006, American Journal of Geriatric Psychiatry
      Citation Excerpt :

      IF was also found to be correlated with cortisol levels, which are known to be elevated in depressed individuals.34 Another study indicated that a decrease in serum triglycerides was associated with a decrease in depressive symptoms among patients who underwent a year of treatment for hypertriglyceridemia.35 The authors speculated that increased triglycerides are causal in depression.

    • Behavioral implications of lowering cholesterol levels: A double-blind pilot study

      2003, Psychosomatics
      Citation Excerpt :

      Glueck et al.21 found that pharmacological and dietary treatment of hypertriglyceridemia was associated with a significant amelioration of depressive symptoms at 30 and 54 weeks. They suggested that the apparent antidepressant effects were possibly due to improved cerebral perfusion and oxygenation.21 Individual risk factors for experiencing behavioral change with cholesterol-lowering drug treatments are unknown.

    View all citing articles on Scopus

    Supported by Jewish Hospital Medical Research Council Grant #790.

    View full text